Do you remember exactly where you were when you learned of the Sept. 11 terrorist attacks? Your answer is probably yes, and researchers are beginning to understand why we remember events that carry negative emotional weight.
Men may be more willing than women to sacrifice achievement goals for a romantic relationship, according to a new study by Catherine Mosher of Duke Medical Center and Sharon Danoff-Burg from the University of Albany.
A novel software application will help engineers and planners select the most efficient and site specific methods of controlling the amount of pollutants that enter the receiving waters through stormwater runoff.
Sleep disorder and ear, nose and throat specialists at Thomas Jefferson University are examining an innovative procedure to treat obstructive sleep apnea syndrome.
World renowned experts on motor neurone disease will share their work at an international symposium hosted by the University of Edinburgh to enable greater understanding of the condition.
What keeps a newly licensed nurse on the job” Answers to that question are important to hospitals across the U.S., many of which are confronting serious nursing shortages.
A study, published in the September issue of the American Journal of Nursing (AJN), provides new insight into the work experiences of newly-licensed RNs that may help reduce the turnover rate of hospital nurses.
Baxter International Inc. (NYSE: BAX) and The Alzheimer?s Disease Cooperative Study (ADCS) group announced the decision to pursue a multi-center U.S. Phase III study evaluating the role of Gammagard Liquid [Immune Globulin Intravenous (Human)] (IGIV) , an intravenous immunoglobulin preparation, for the treatment of patients with mild to moderate Alzheimer?s disease.
University of Arkansas researchers have found a simple, inexpensive way to create a nanowire coating on the surface of biocompatible titanium that can be used to create more effective surfaces for hip replacement, dental reconstruction and vascular stenting.
University of Minnesota researchers have discovered that treating people who have early cardiovascular abnormalities, but show no symptoms of cardiovascular disease, can slow progression and even reverse damage to the heart and blood vessels.